Related Content
April 9, 2020 — Abbott announced its TriClip Transcatheter Tricuspid Valve Repair (TTVR) System has received European CE ...
March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA ...
February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...
February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess ...
January 30, 2020 — The Abbott Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received European CE mark ...
January 13, 2020 — The U.S. Food and Drug Administration (FDA) has approved clinical trial that will compare the ...
January 7, 2020 — Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical ...
November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a ...
November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...
November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...